Acacia Research Corp. (ACTG) director Gavin Molinelli acquired 6,961 shares of common stock on September 30, 2026, as a grant in lieu of cash for Q3 2026 director fees. The transaction lists a price of $4.31 per share. Afterward, Molinelli directly held 212,927 shares. This was a compensation-related award, not a market transaction.
ACACIA RESEARCH CORP (ACTG) director Isaac T. Kohlberg reported selling 24,000 shares of ACTG common stock on September 15, 2026 in an open-market or private transaction at a weighted average price of $4.55, with individual trade prices ranging from $4.55 to $4.56. After this sale, he reports owning 54,310 shares directly. No Rule 10b5-1 trading plan is reported for this transaction.
ACACIA RESEARCH CORP (ACTG) received a Rule 144 notice indicating that stockholder Isaac T. Kohlberg plans to sell up to 24,000 shares of Common Stock, with an approximate aggregate market value of $110,000, as of September 15, 2026, on the Nasdaq Global Select market.
The notice also reports that Kohlberg previously received 30,534 restricted shares from the issuer on May 26, 2023 for services rendered, and that 32,188 shares of Common Stock were sold during the past three months for $150,318.
ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling a total of 33,000 shares of ACTG common stock in open market or private transactions. On September 2, 2026, she sold 20,534 shares at a weighted average price of $4.63 per share, in multiple trades between $4.615 and $4.645. On September 3, 2026, she sold 12,466 shares at a weighted average price of $4.57 per share, in multiple trades between $4.51 and $4.66. No Rule 10b5-1 trading plan is reported, and post-transaction share holdings are not stated.
Acacia Research Corporation (ACTG) is the issuer of common stock for which director Maureen E. O'Connell has filed a notice under Rule 144 to sell up to 33,000 shares through UBS Financial Services Inc. The shares relate to RSU vestings on May 12, 2022 and May 26, 2024 and are planned for sale on or after September 2, 2026. The filing also lists a prior sale of 10,000 shares in the past three months.
ACACIA RESEARCH CORP (ACTG) director Michelle Felman reported two bona fide gift transactions of ACTG common stock on August 28, 2026. In total, she gifted 32,172 shares, at a reported reference value of $4.49 per share, to an irrevocable trust established for the benefit of her son, for no consideration.
ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling 10,000 shares of ACTG common stock on 2026-08-19 in an open-market transaction. The weighted average sale price was $4.60 per share, with individual trades between $4.57 and $4.63. Following this sale, she directly holds 287,655 shares of ACTG common stock.
Acacia Research Corporation (ACTG) director Maureen E. O'Connell filed a Rule 144 notice to sell up to 10,000 shares of ACTG common stock through UBS Financial Services Inc. The shares relate to RSU vesting on 05/26/2024, with the proposed sale by 08/19/2026 on NASDAQ.
Acacia Research Corp director Isaac T. Kohlberg reported an open-market sale of 32,188 shares of ACTG common stock on 2026-08-12. The shares were sold at a weighted average price of $4.67 per share, with individual trades executed between $4.66 and $4.69. Following this transaction, Kohlberg directly holds 78,310 ACTG shares. The filing does not indicate that the sale was made under a Rule 10b5-1 trading plan.
Acacia Research Corporation (ACTG) has a notice from an affiliate indicating an intention to sell up to 32,188 shares of common stock, with an aggregate market value of $150,199.00, on or after August 12, 2026 on the Nasdaq Global Select Market.
The filing also lists prior issuances of restricted stock by the issuer for services rendered, including 30,534 shares granted on May 26, 2023 and 32,172 shares granted on May 30, 2025.